On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer's disease.
1. Alzheimer's disease (AD) is pathologically defined by the deposition of amyloid peptide and neurofibrillary tangles and is characterized by a progressive loss of cognition and memory function, due to marked cortical cholinergic depletion. 2. Cholinergic cortical innervation is provided by basal forebrain cholinergic neurons. The neurotrophin Nerve Growth Factor (NGF) promotes survival and differentiation of basal forebrain cholinergic neurons. 3. This assertion has been at the basis of the hypothesis developed in the last 20 years, whereby NGF deprivation would be one of the factor involved in the etiology of sporadic forms of AD. 4. In this review, we shall summarize data that lead to the production and characterization of a mouse model for AD (AD11 anti-NGF mice), based on the expression of transgenic antibodies neutralizing NGF. The AD-like phenotype of AD11 mice will be discussed on the basis of recent studies that have posed NGF and its precursor pro-NGF back to the stage of AD-like neurodegeneration, showing the involvement of the precursor pro-NGF in one of the cascades leading to AD neurodegeneration.
Capsoni
Simona
S
Lay Line Genomics S.p.A., Via di Castel Romano 100, 00128, Rome, Italy. s.capsoni@laylinegenomics.com
Cattaneo
Antonino
A
D000544:Alzheimer Disease / Q000209:etiology*; D000818:Animals; D004195:Disease Models, Animal; D051379:Mice; D008954:Models, Biological; D020932:Nerve Growth Factor / Q000502:physiology*; D017475:Receptors, Nerve Growth Factor / Q000502:physiology
D017475:Receptors, Nerve Growth Factor; D020932:Nerve Growth Factor